Page last updated: 2024-09-03

ezogabine and Anhedonia

ezogabine has been researched along with Anhedonia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bagiella, E; Bevilacqua, L; Chadha, N; Collins, KA; Corniquel, M; Costi, S; Han, MH; Hoch, M; Iosifescu, DV; Iqbal, T; Jha, MK; Kirkwood, KA; Mathew, SJ; Morris, LS; Murrough, JW; Parides, MK; Pizzagalli, DA; Salas, R; Stern, ER; Swann, AC; Ursu, S; Vo-Le, B; Whitton, A	1

Trials

1 trial(s) available for ezogabine and Anhedonia

Article	Year
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial. The American journal of psychiatry, 2021, 05-01, Volume: 178, Issue:5 Topics: Adult; Anhedonia; Carbamates; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Functional Neuroimaging; Humans; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Magnetic Resonance Imaging; Male; Membrane Transport Modulators; Middle Aged; Phenylenediamines; Reward; Ventral Striatum	2021

Article

Year

Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.

The American journal of psychiatry, 2021, 05-01, Volume: 178, Issue:5

Topics: Adult; Anhedonia; Carbamates; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Functional Neuroimaging; Humans; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Magnetic Resonance Imaging; Male; Membrane Transport Modulators; Middle Aged; Phenylenediamines; Reward; Ventral Striatum

2021